Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01773785
What this trial is testing

Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer

Who this might be right for
Biliary Cancer
Spectrum Pharmaceuticals, Inc 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919848
What this trial is testing

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Who this might be right for
Biliary Tract Cancer (BTC)
Fudan University 74
Testing effectiveness (Phase 2)Looking for participantsNCT06708858
What this trial is testing

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Dai, Guanghai 35
Large-scale testing (Phase 3)Study completedNCT00939848
What this trial is testing

Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Neoplasms
University College, London 124
Testing effectiveness (Phase 2)UnknownNCT03772132
What this trial is testing

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465563
What this trial is testing

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 93
Testing effectiveness (Phase 2)Ended earlyNCT00955721
What this trial is testing

Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaBiliary Tract CancerGallbladder Cancer
University of Miami 9
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT02558959
What this trial is testing

Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
Zhejiang University 64
Large-scale testing (Phase 3)Looking for participantsNCT07710885
What this trial is testing

Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Taiho Pharmaceutical Co., Ltd. 784
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT04956640
What this trial is testing

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal NeoplasmsEndometrial Neoplasms+3 more
Eli Lilly and Company 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)WithdrawnNCT04571710
What this trial is testing

A Trial of SHR1258 in Patients With Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT02988635
What this trial is testing

Early Palliative Care on Quality of Life of Advanced Cancer Patients

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Cancer+1 more
Azienda Ospedaliero-Universitaria di Parma 281
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01007552
What this trial is testing

Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Who this might be right for
Cholangiocarcinoma
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)UnknownNCT04004234
What this trial is testing

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Who this might be right for
Biliary Tract Cancer (BTC)
Chinese PLA General Hospital 20
Large-scale testing (Phase 3)Study completedNCT03768414
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Who this might be right for
Stage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8+14 more
SWOG Cancer Research Network 452
Next Page